Royalty Pharma plc (RPRX) Revenue History
Royalty Pharma plc (RPRX) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2020-12-31 | $2.12B |
| 2021-12-31 | $2.29B |
| 2022-12-31 | $2.24B |
| 2023-12-31 | $2.35B |
| 2024-12-31 | $2.26B |
| 2025-12-31 | $2.38B |
How RPRX compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| PODD | Insulet Corporation | $2.71B |
| BIO | Bio-Rad Laboratories Inc. Class A | $2.58B |
| EXEL | Exelixis Inc. | $2.32B |
| NTRA | Natera Inc. | $2.31B |
| ICUI | ICU Medical Inc. | $2.23B |
These are five companies in the same sector as RPRX with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Royalty Pharma plc Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("RPRX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RPRX | $58.56 | -1.11% | 2.52M |
| 3 | ||||
| 4 | ||||
| 5 |